Pacific Biosciences of California launches PacBioPRISM tour finale in Japan to drive HiFi innovation

Pacific Biosciences of California launches PacBioPRISM tour finale in Japan to drive HiFi innovation
PacBioPRISM finale drives innovation

Pacific Biosciences of California has commenced the final stop of its PacBioPRISM world tour in Fukuoka, Japan. The event brings together the genomics community for a week focused on new research and advancements in HiFi sequencing technology.

As participants gather to share insights and discuss the future of genomics, the tour highlights ongoing efforts toward innovative solutions in the field. Updates from the event are expected to provide key developments in genomic research and technology.

Pacific Biosciences of California recently reported gains in sequencing accuracy and lower genome costs driven by AI and DeepConsensus. The company has also updated its SMRT Cell Sequencing 101 guide to reflect new HiFi methods and SPRQ-Nx chemistry. These developments follow its ongoing efforts to advance sequencing technology and resources.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.